grant

Sensitive periods for interneuron development supporting cognitive flexibility

Organization NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INCLocation NEW YORK, UNITED STATESPosted 1 Aug 2022Deadline 31 May 2027
NIHUS FederalResearch GrantFY202512-20 years old21+ years old4-Aminobutanoic Acid4-Aminobutyric Acid4-amino-butanoic acidAD dementiaAD/HDADHDAcuteAddressAdolescenceAdultAdult HumanAffectAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimers DementiaAminalonAminaloneAnatomic SitesAnatomic structuresAnatomyAttentionAttention deficit hyperactivity disorderBehaviorBehavioralCell BodyCellsCognitionCognitiveCognitive deficitsConnector NeuronCyclic SomatostatinD CellsDREADDsDataDelta CellDevelopmentDimensionsDysfunctionFearFrequenciesFrightFunctional disorderGABAGeneticGrowth Hormone Inhibiting FactorsGrowth Hormone-Inhibiting HormoneHumanImpairmentInfantIntercalary NeuronIntercalated NeuronsInterneuronsInternuncial CellInternuncial NeuronKnowledgeLearningLinkMeasuresMental disordersMental health disordersMiceMice MammalsModern ManMolecularMonitorMurineMusNerve CellsNerve UnitNervous System DiseasesNervous System DisorderNeural CellNeurobiologyNeurocyteNeurologic DisordersNeurological DisordersNeuronsOutcome AssessmentOutputP32P32 isotopeParalysis AgitansParkinsonParkinson DiseaseParvalbuminsPerformancePhosphocol P32Phosphorus 32Phosphorus P32PhysiologicPhysiologicalPhysiologyPhysiopathologyPredominantly Hyperactive-Impulsive Type Attention-Deficit DisorderPredominantly Hyperactive-Impulsive Type Hyperactivity DisorderPrefrontal CortexPrimary ParkinsonismPrimary Senile Degenerative DementiaPsychiatric DiseasePsychiatric DisorderPubertyPyramidal CellsReceptor ProteinRodentRodentiaRodents MammalsRoleSRIHSRIH-14SchizophreniaSchizophrenic DisordersSomatostatinSomatostatin CellsSomatostatin Secreting CellSomatostatin-14Somatotropin Release Inhibiting FactorsSomatotropin Release-Inhibiting HormoneSourceSynapsesSynapticSystemTestingTimeWorkaddictionaddictive disorderadolescence (12-20)adulthoodbehavior outcomebehavioral outcomecell typecognitive abilitycognitive defectscognitive processdementia praecoxdesigner receptors exclusively activated by designer drugsdevelopmentalearly adolescenceexecutive controlexecutive functionflexibilityflexiblefunctional outcomesgamma-Aminobutyric Acidgrowth hormone release inhibiting factorinsightmental illnessneurobiologicalneurological diseaseneuronalneuropsychiatric diseaseneuropsychiatric disorderoptogeneticspathophysiologypost-natal developmentpostnatalpostnatal developmentprimary degenerative dementiaprogramspsychiatric illnesspsychological disorderreceptorschizophrenicsenile dementia of the Alzheimer typesocial rolesynapsetheoriesγ-Aminobutyric Acid
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Cognitive flexibility is a core component of executive functioning that is impaired in a range of neuropsychiatric
disorders. The prefrontal cortex (PFC) supports cognitive flexibility in the adult, and alterations in prefrontal

function likely contribute to impairments in this cognitive process. Cognitive flexibility, like other aspects of

executive functioning, develops slowly across postnatal development. Developmental refinement of prefrontal

circuitry and function is theorized to underlie the protracted acquisition of cognitive abilities, and abnormalities in

this refinement may contribute to deficits in prefrontal circuitry and function in the context of psychiatric disorders.

While the early stages of prefrontal circuit development are largely governed by genetic programs, subsequent

circuit refinement is heavily dependent on activity. Postnatal maturation of GABAergic tone is poised to

powerfully regulate cortical activity—providing a source of excitability during the first postnatal week that rapidly

changes to inhibition thereafter. Importantly, developmental dysfunction of interneurons, especially those

expressing parvalbumin (PV) or somatostatin (SST), is linked with impaired set-shifting behavior and prefrontal

circuit function in adulthood. Yet, how activity in PV and SST interneurons influences prefrontal

circuit development—including the development of the interneurons themselves—during different developmental

time windows is a fundamental gap in our knowledge. Further, once mature connectivity is established, how SST

and PV interneurons work together to engage cortical activity to support cognitive flexibility in adulthood, remains

unknown.

We hypothesize that during early postnatal development, prefrontal SST activity is required for establishing

increasing thalamocortical drive onto PV cells that, in turn, sustains and augments the strength of the connections

these PV cells make onto pyramidal cells, and that PV activity subsequently iteratively refines the strength of

incoming excitatory drive from cortical and subcortical sources. This developmental maturation in activity

establishes proper connectivity of PV and SST interneurons in adulthood, whose activity is essential for mature

prefrontal network function supporting cognitive flexibility. To test this hypothesis, in Aim 1 we will examine how

PV and SST interneurons organize PFC network activity to support extra dimensional attentional set shifting in

adult mice. In Aim 2, we will test how inhibiting activity of prefrontal PV or SST interneurons during different

developmental windows using the DREADD receptor, hM4DGi, affects adult network function and behavior using

the physiological and behavioral outcomes assessed in Aim 1. Understanding how PV and SST interneurons

support cognition, and how developmental perturbations of these cells affect adult PFC function, will provide

insight into neurobiological origins of cognitive deficits in psychiatric disorders and more broadly into the role of

cell-type selective GABA release in sculpting the developing PFC.

Grant Number: 5R01MH128277-04
NIH Institute/Center: NIH

Principal Investigator: SARAH CANETTA

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →